These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 8860838)
1. Modification of tumor suppressor gene expression in non-small cell lung cancer (NSCLC) with a retroviral vector expressing wildtype (normal) p53. Roth JA Hum Gene Ther; 1996 May; 7(7):861-74. PubMed ID: 8860838 [No Abstract] [Full Text] [Related]
2. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC). Roth JA Hum Gene Ther; 1996 May; 7(7):875-89. PubMed ID: 9147520 [No Abstract] [Full Text] [Related]
3. Modification of tumor suppressor gene expression and induction of apoptosis in non-small cell lung cancer (NSCLC) with an adenovirus vector expressing wildtype p53 and cisplatin. Roth JA Hum Gene Ther; 1996 May; 7(8):1013-30. PubMed ID: 8727511 [No Abstract] [Full Text] [Related]
4. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864 [TBL] [Abstract][Full Text] [Related]
5. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Fujiwara T; Grimm EA; Mukhopadhyay T; Cai DW; Owen-Schaub LB; Roth JA Cancer Res; 1993 Sep; 53(18):4129-33. PubMed ID: 8395976 [TBL] [Abstract][Full Text] [Related]
14. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients. Boulay JL; Perruchoud AP; Reuter J; Bolliger C; Herrmann R; Rochlitz C Cancer Gene Ther; 2000 Sep; 7(9):1215-9. PubMed ID: 11023193 [TBL] [Abstract][Full Text] [Related]
15. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Swisher SG; Roth JA; Komaki R; Gu J; Lee JJ; Hicks M; Ro JY; Hong WK; Merritt JA; Ahrar K; Atkinson NE; Correa AM; Dolormente M; Dreiling L; El-Naggar AK; Fossella F; Francisco R; Glisson B; Grammer S; Herbst R; Huaringa A; Kemp B; Khuri FR; Kurie JM; Liao Z; McDonnell TJ; Morice R; Morello F; Munden R; Papadimitrakopoulou V; Pisters KM; Putnam JB; Sarabia AJ; Shelton T; Stevens C; Shin DM; Smythe WR; Vaporciyan AA; Walsh GL; Yin M Clin Cancer Res; 2003 Jan; 9(1):93-101. PubMed ID: 12538456 [TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers. Huang CL; Yokomise H; Miyatake A Future Oncol; 2007 Feb; 3(1):83-93. PubMed ID: 17280505 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study of adenoviral mediated p53 gene therapy for non-small cell lung cancer in Japan]. Kagawa S; Fujiwara T; Tanaka N Gan To Kagaku Ryoho; 2003 Feb; 30(2):193-7. PubMed ID: 12610865 [TBL] [Abstract][Full Text] [Related]
19. CT-guided intratumoral gene therapy in non-small-cell lung cancer. Kauczor HU; Schuler M; Heussel CP; von Weymarn A; Bongartz G; Rochlitz C; Huber C; Thelen M Eur Radiol; 1999; 9(2):292-6. PubMed ID: 10101653 [TBL] [Abstract][Full Text] [Related]